Qualitative analysis of the viability of autogenous fat grafts grafted in different environments of interstitial pressure. Preliminary results and description of a new experimental model in mini-pigs

Acta Cir Bras. 2017 Nov;32(11):891-902. doi: 10.1590/s0102-865020170110000001.

Abstract

Purpose: To evaluate the feasibility of an experimental model of autologous fat graft (AFG) in different interstitial pressure (IP) environments.

Methods: Three mini-pigs(Minipig-BR) with age of 8 months (weight: 25-30 kg) were used. AFG were collected from the bucal fat pad, and grafted in the intramuscular pocket (biceps femoralis muscle). IP model was based on a fusiform ressection followed by primary closure "under tension". A blood pressure catheter located in the intramuscular region connected to a pressure module was applied to quantify IP.

Results: The mean operative time was 236 min (210 - 272 min). All the AFG and muscular segments were removed successfully. Average interstitial pressure CP and H were 3 and 10.6 mmHg respectively. The AFG were biopsied for histopathological analysis 30 days after graft. Hematoxylin-eosin staining and immunohistochemical analyzes (TNF-alpha, CD31 and Perilipine with monoclonal antibodies) were employed.

Conclusion: The data show that minipigs model could be used as a recipient site for autologous fat graft techniques and allow the development of studies to explore the AFG intake and pathophysiology response.

MeSH terms

  • Adipose Tissue / transplantation*
  • Animals
  • Disease Models, Animal*
  • Feasibility Studies
  • Graft Survival
  • Immunohistochemistry
  • Male
  • Perilipins / analysis
  • Plastic Surgery Procedures / methods*
  • Plastic Surgery Procedures / standards
  • Platelet Endothelial Cell Adhesion Molecule-1 / analysis
  • Pressure
  • Swine
  • Swine, Miniature
  • Transplantation, Autologous / methods*
  • Transplantation, Autologous / standards
  • Tumor Necrosis Factor-alpha

Substances

  • Perilipins
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Tumor Necrosis Factor-alpha